483
Dedicated Phase I, Inc.FDA 483 - Dedicated Phase I, Inc. - March 16, 2012
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
During an inspection, Dedicated Phase I, Inc. was cited for failing to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, a required blood sample was not taken from a subject during a clinical trial. This indicates a deviation from protocol in a clinical research setting.
Open in Dashboard
ID · 2252d94c-1945-4069-bff3-5e55ddd691e2